Compare MORN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MORN | AMRX |
|---|---|---|
| Founded | 1984 | 2002 |
| Country | United States | United States |
| Employees | N/A | 8500 |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.4B |
| IPO Year | 2004 | 2018 |
| Metric | MORN | AMRX |
|---|---|---|
| Price | $197.87 | $19.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $256.50 | $15.60 |
| AVG Volume (30 Days) | 246.0K | ★ 2.0M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.07% | N/A |
| EPS Growth | 3.38 | ★ 157.89 |
| EPS | ★ 5.55 | 0.37 |
| Revenue | ★ $2,445,500,000.00 | N/A |
| Revenue This Year | $9.14 | $4.48 |
| Revenue Next Year | $7.23 | $7.13 |
| P/E Ratio | ★ $36.09 | $52.24 |
| Revenue Growth | ★ 7.49 | N/A |
| 52 Week Low | $141.49 | $9.56 |
| 52 Week High | $238.04 | $21.18 |
| Indicator | MORN | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.12 | 61.42 |
| Support Level | $189.22 | $16.59 |
| Resistance Level | $204.32 | N/A |
| Average True Range (ATR) | 6.32 | 0.81 |
| MACD | -0.94 | 0.24 |
| Stochastic Oscillator | 58.39 | 60.89 |
Morningstar Inc is a provider of independent investment insights to financial advisers, asset managers, and investors. It provides data and research insights on various investment offerings, including managed investment products, publicly listed companies, private capital markets, debt securities, and real-time market data. The company has five reportable segments: Morningstar Direct Platform, PitchBook, Morningstar Credit, Morningstar Wealth, and Morningstar Retirement. Maximum revenue is derived from the Morningstar Direct Platform, which provides investors with comprehensive data, research, insights, and investment analysis through product areas such as Morningstar Data, Morningstar Direct, and Morningstar Advisor Workstation. Geographically, it generates maximum revenue from the USA.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.